A study was conducted to compare the effects of an antibiotic growth promoter (flavomycin) and two herbal natural feed additives (garlic and thyme) with and without a xylanase-based enzyme complex in wheat-based diets on growth performance, carcass parameters, total plasma cholesterol concentration, intestinal traits and the dry matter content of excreta of broiler chickens. A total of 112 day-old male broiler chicks was randomly assigned to eight groups containing 14 chicks each and raised from 1 to 42 days of age. The control group received the wheat-soyabean meal basal diet. In the treatment groups the basal diet was supplemented with one of the following: an antibiotic, thyme, garlic, an enzyme, the antibiotic plus the enzyme, thyme plus the enzyme or garlic plus the enzyme. During the 42-d growth period there were no significant differences in body weight gain, feed intake and feed conversion ratio of the broilers between dietary treatments. Feeding the diet supplemented with the antibiotic plus the enzyme significantly increased hot and cold carcass yields compared to the diets supplemented with thyme, garlic, enzyme and garlic plus enzyme. Total plasma cholesterol concentration, the dry matter content of excreta and the relative weights of the heart, pancreas, liver, gizzard and spleen were not significantly influenced by dietary treatments. The relative weight of the small intestines of the broilers receiving the diets supplemented with the antibiotic, antibiotic plus enzyme, thyme plus enzyme and garlic plus enzyme were significantly less than those of the broilers fed the basal diet and the diets supplemented with thyme, garlic and enzyme. The basal diet and garlic supplemented diet significantly increased the length of the small intestine compared to the other dietary treatments. Broilers receiving the diet supplemented with antibiotic had significantly lower total aerobic bacterial counts in the small intestines compared to those on the other dietary treatments. The combined supplementation of the antibiotic and enzyme resulted in a significantly lower E. coli concentration in the small intestines compared to the basal diet and the other dietary treatments.
An eighty‐day feeding study was performed to investigate the effects of mealworm meal (Tenebrio molitor) on the growth, survival and moulting frequency of juvenile Narrow‐clawed crayfish (Pontastacus leptodactylus). Three dietary treatment groups with triplicate were fed with a fish meal‐based without MW (control diet: MW0), two diets with 50% (MW50) and 100% (Mw100) of fish meal substitution with MW respectively. P. leptodactylus juveniles (11.0 ± 0.05 mm, mean ±SE and 0.011 ± 0.002 g, mean ±SE) were randomly stocked into nine flow‐through tanks with a density of 30 crayfish per tank and reared for 80 days. Crayfish fed with MW50 mealworm meal showed positive effects on weight gain (WG), specific growth rate (SGR), protein efficiency ratio (PER), apparent net protein utilization (ANPU), moulting frequency (MF) and feed conservation ratio (FCR), but lower survival rate (SR) as compared to the other diet groups. Protein and lipid contents of the whole body of the crayfish fed with replacement diet (MW50) were found to be higher than those of the other two diet groups (p<0.05). However, the MW100 diet slightly increased the moisture and ash contents of the crayfish. Our observation indicated that the addition of a 50% mealworm meal in the diet of P. leptodactylus juveniles improved the growth performance of the crayfish without causing any adverse effects. Therefore, T. molitor meal can be considered as an alternative animal source of protein for the narrow‐clawed crayfish juveniles.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.